Title Slide
|
Figure 9.
Gonorrhea - Reported rates: United States, 1970-2001 and the
Healthy People year 2010 objective
|
Figure 10:
Rates by state: United States and outlying areas, 2001
|
Figure 11:
Rates by region: United States, 1981–2001 and the Healthy
People year 2010 objective
|
Figure 12:
Rates by sex: United States, 1981–2001 and the Healthy
People year 2010 objective
|
Figure 13: Rates by
race and ethnicity: United States, 1981–2001 and
the Healthy People year 2010 objective
|
Figure 14: Age
and sex specific rates: United States, 2001
|
Figure 15:
Positivity among 15_24 year old women tested in family planning
clinics by state, 2001
|
Figure 16:
Gonococcal Isolate Surveillance Project (GISP) - Location of
participating clinics and regional laboratories: United States,
2001
|
Figure 17:
Gonococcal Isolate Surveillance Project (GISP) - Penicillin and
tetracycline resistance among GISP isolates, 2001
|
Figure 18:
Gonococcal Isolate Surveillance Project (GISP) - Percent of
Neisseria gonorrhoeae isolates with decreased susceptibility or
resistance to ciprofloxacin, 1990-2001
|
Figure 19:
Gonococcal Isolate Surveillance Project (GISP) - Percent of men
with gonorrhea who had a previous gonorrhea infection, 1991-2001
|